Armistice Capital’s Biogen BIIB Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-100,049	Closed	-$21.6M	–	269
2024 Q1	$21.6M	Sell	100,049 -99,951	-50%	-$21.6M	0.29%	62
2023 Q4	$51.8M	Sell	200,000 -76,788	-28%	-$19.9M	0.71%	23
2023 Q3	$71.1M	Buy	276,788 +20,788	+8%	+$5.34M	1.09%	6
2023 Q2	$72.9M	Sell	256,000 -194,000	-43%	-$55.3M	1.06%	12
2023 Q1	$125M	Buy	450,000 +50,000	+13%	+$13.9M	1.8%	7
2022 Q4	$111M	Buy	400,000 +176,000	+79%	+$48.7M	1.93%	7
2022 Q3	$59.8M	Sell	224,000 -12,000	-5%	-$3.2M	1.04%	21
2022 Q2	$48.1K	Sell	236,000 -336,000	-59%	-$68.5K	0.84%	29
2022 Q1	$120M	Buy	572,000 +112,000	+24%	+$23.6M	2.33%	3
2021 Q4	$110M	Buy	460,000 +88,000	+24%	+$21.1M	1.81%	7
2021 Q3	$105M	Buy	372,000 +4,000	+1%	+$1.13M	1.78%	6
2021 Q2	$127M	Buy	368,000 +80,000	+28%	+$27.7M	2.28%	2
2021 Q1	$80.6M	Buy	288,000 +30,000	+12%	+$8.39M	1.85%	9
2020 Q4	$63.2M	Buy	258,000 +158,000	+158%	+$38.7M	2.15%	7
2020 Q3	$28.4M	Sell	100,000 -116,000	-54%	-$32.9M	1.03%	36
2020 Q2	$57.8M	Buy	216,000 +158,000	+272%	+$42.3M	2.53%	4
2020 Q1	$18.4M	Sell	58,000 -70,000	-55%	-$22.1M	1.13%	34
2019 Q4	$38M	Sell	128,000 -20,000	-14%	-$5.93M	2.19%	5
2019 Q3	$34.5M	Buy	148,000 +120,000	+429%	+$27.9M	2.28%	10
2019 Q2	$6.55M	Sell	28,000 -122,000	-81%	-$28.5M	0.41%	42
2019 Q1	$35.5M	Buy	+150,000	New	+$35.5M	1.94%	12